Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Conference
May 03 2022 - 7:00AM
Krystal Biotech, Inc., (the “Company”) (NASDAQ: KRYS), the leader
in redosable gene therapy, today announced that Krish S.
Krishnan, Chairman and Chief Executive Officer, will participate in
the Bank of America Merrill Lynch Global Healthcare Conference.
Details for the event are as follows:
Bank of America Merrill Lynch Global Healthcare
Conference |
Date: |
|
Tuesday, May 10, 2022 |
Time: |
|
9:20am PDT |
Webcast Link: |
|
https://bofa.veracast.com/webcasts/bofa/hc2022/id6InQpA.cfm |
A webcast of the presentation will be available
on the Investors section of the Company’s website for 90 days
following the presentation.
About Krystal Biotech
Krystal Biotech, Inc. (NASDAQ: KRYS) is a
pivotal-stage gene therapy company leveraging its proprietary,
redosable gene therapy platform and in-house manufacturing
capabilities to develop life-changing treatment options for
patients with serious diseases, including rare diseases in skin,
lung, and other areas. For more information, please
visit http://www.krystalbio.com and follow
@KrystalBiotech on LinkedIn and Twitter.
CONTACT:
Investors and Media:Meg DodgeKrystal
Biotechmdodge@krystalbio.com
Source: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024